Co-Occurrence of Lower Urinary Tract Symptoms and Frailty among Community-Dwelling Older Men.

TitleCo-Occurrence of Lower Urinary Tract Symptoms and Frailty among Community-Dwelling Older Men.
Publication TypeJournal Article
Year of Publication2020
AuthorsBauer, SR, Scherzer, R, Suskind, AM, Cawthon, P, Ensrud, KE, Ricke, WA, Covinsky, K, Marshall, LM
Corporate Authors
JournalJ Am Geriatr Soc
Volume68
Issue12
Pagination2805-2813
Date Published2020 Dec
ISSN1532-5415
KeywordsAge Factors, Aged, Comorbidity, Cross-Sectional Studies, Frailty, Humans, Independent Living, Lower Urinary Tract Symptoms, Male, Prevalence, Risk Factors, Surveys and Questionnaires, United States, Urinary Incontinence
Abstract

BACKGROUND/OBJECTIVES: To estimate associations between lower urinary tract symptoms (LUTS) and phenotypic frailty in older men.

DESIGN: Cross-sectional study.

SETTING: Community-dwelling men recruited from 2000 to 2002 from six U.S. academic centers for the Osteoporotic Fractures in Men Study.

PARTICIPANTS: A total of 5,979 men aged 65 and older.

MEASUREMENTS: The independent variable was LUTS severity (none/mild, moderate, or severe) assessed with the American Urologic Association Symptom Index. Participants were categorized as frail, intermediate stage, or robust using an adapted Cardiovascular Health Study index (components: low lean mass, weakness, exhaustion, slowness, and low physical activity). Associations were estimated with odds ratios and 95% confidence intervals (CIs) from multivariable multinomial logistic regression models adjusted for potential confounders of age, other demographics, health-related behaviors, and comorbidities.

RESULTS: The prevalence of frailty was 7%, 11%, and 18% among men with none/mild, moderate, and severe LUTS, respectively. Moderate and severe LUTS, overall and by storage and voiding subscores, were associated with higher odds of both intermediate stage and frailty in all models. After adjustment for confounders, the odds of frailty was 1.41 times higher among men with moderate LUTS (95% CI = 1.14-1.74) and 2.51 times higher among men with severe LUTS (95% CI = 1.76-3.55), compared with none/mild LUTS. Severe LUTS was associated with a greater odds of individual frailty components exhaustion and low physical activity.

CONCLUSION: The prevalence of phenotypic frailty is higher among older community-dwelling men with moderate or severe LUTS compared with those with mild or no LUTS. The positive association between LUTS severity and frailty among older men appears independent of age and known frailty risk factors. Although the temporal direction of this association and the utility of LUTS or frailty interventions in this population remain unclear, the high co-occurrence of these conditions could lead to earlier identification of frailty when clinically appropriate.

DOI10.1111/jgs.16766
Alternate JournalJ Am Geriatr Soc
PubMed ID32822081
PubMed Central IDPMC7744321
Grant ListUL1 TR000128 / TR / NCATS NIH HHS / United States
U01 AR45654 / AR / NIAMS NIH HHS / United States
R01 AG066671 / AG / NIA NIH HHS / United States
U01 AG042145 / AG / NIA NIH HHS / United States
U01 AR045614 / AR / NIAMS NIH HHS / United States
1K12DK111028 / DK / NIDDK NIH HHS / United States
U01 AR45632 / AR / NIAMS NIH HHS / United States
U01 AR45583 / AR / NIAMS NIH HHS / United States
U01 AR045647 / AR / NIAMS NIH HHS / United States
U01 AG027810 / AG / NIA NIH HHS / United States
U01 AR45647 / AR / NIAMS NIH HHS / United States
U01 AG18197 / NH / NIH HHS / United States
U01 AR045654 / AR / NIAMS NIH HHS / United States
R03 AG067937 / AG / NIA NIH HHS / United States
U01 AR45614 / AR / NIAMS NIH HHS / United States
K12 DK111028 / DK / NIDDK NIH HHS / United States
U01 AR045583 / AR / NIAMS NIH HHS / United States
U01 AR45580 / AR / NIAMS NIH HHS / United States
R56 AG061085 / AG / NIA NIH HHS / United States
U01 AR045580 / AR / NIAMS NIH HHS / United States
P30 AG044281 / AG / NIA NIH HHS / United States
U54 104310 / NH / NIH HHS / United States
U01 AG018197 / AG / NIA NIH HHS / United States
U01 AR045632 / AR / NIAMS NIH HHS / United States
U54 DK104310 / DK / NIDDK NIH HHS / United States